Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
作者信息
de Chaisemartin Luc, Diep Antoine, Gonnin Cécile, Soria Angèle, Barbaud Annick, Nicaise-Roland Pascale
机构信息
Service Auto-immunité, Hypersensibilité et Biothérapies, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France; Insitut National de la Santé Et de la Recherche Médicale UMR 996, Université Paris-Saclay, Châtenay-Malabry, France.
Service Auto-immunité, Hypersensibilité et Biothérapies, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Paris, France.
出版信息
Ann Allergy Asthma Immunol. 2022 Mar;128(3):338-339. doi: 10.1016/j.anai.2021.11.012.
Abstract
摘要
相似文献
1
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?2019年冠状病毒病信使核糖核酸疫苗过敏反应期间的免疫参数：并非常见因素？
Ann Allergy Asthma Immunol. 2022 Mar;128(3):338-339. doi: 10.1016/j.anai.2021.11.012.
2
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.mRNA新冠疫苗在患有皮肤和全身性肥大细胞增多症且伴有肥大细胞活化症状和过敏反应的患者中耐受性良好。
J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.
3
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions.2019冠状病毒病信使核糖核酸疫苗皮肤试验及过敏反应中的血清组胺水平
Ann Allergy Asthma Immunol. 2022 Mar;128(3):339. doi: 10.1016/j.anai.2021.12.014.
4
Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination.特应性疾病患者近期接种2019冠状病毒病疫苗后的过敏反应风险。
Ann Allergy Asthma Immunol. 2021 Aug;127(2):257-258. doi: 10.1016/j.anai.2021.04.024. Epub 2021 May 5.
5
[COVID-19 vaccines increase the risk of anaphylaxis].[新冠病毒疫苗会增加过敏反应的风险]
Tidsskr Nor Laegeforen. 2021 Feb 16;141(4). doi: 10.4045/tidsskr.21.0109. Print 2021 Mar 9.
6
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.对新型mRNA SARS-CoV-2/COVID-19疫苗的过敏反应。
Vaccine. 2021 Feb 5;39(6):865-867. doi: 10.1016/j.vaccine.2020.12.084. Epub 2021 Jan 6.
7
Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.
8
Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis.对有过敏反应的患者使用2019冠状病毒病信使核糖核酸疫苗进行皮肤试验评估过敏反应风险
Ann Allergy Asthma Immunol. 2022 Jan;128(1):101-103. doi: 10.1016/j.anai.2021.09.021. Epub 2021 Sep 30.
9
Pfizer's vaccine raises allergy concerns.辉瑞公司的疫苗引发了人们对过敏的担忧。
Science. 2021 Jan 1;371(6524):10-11. doi: 10.1126/science.371.6524.10.
10
Immediate reactions after mRNA SARS-CoV-2 vaccination.新型冠状病毒mRNA疫苗接种后的即时反应。
CMAJ. 2021 Dec 6;193(48):E1842. doi: 10.1503/cmaj.211581. Epub 2021 Nov 12.
引用本文的文献
1
Can Labs Help With Vaccination? In Vitro Tests in Diagnosis of Allergy to COVID-19 Vaccines-A Systematic Review.实验室能否助力疫苗接种？新冠疫苗过敏诊断中的体外检测——一项系统评价。
Immun Inflamm Dis. 2025 May;13(5):e70206. doi: 10.1002/iid3.70206.
2
Immediate hypersensitivity to COVID-19 vaccines: Focus on biological diagnosis.对新冠病毒疫苗的速发型超敏反应：聚焦生物学诊断。
Front Allergy. 2022 Sep 30;3:1007602. doi: 10.3389/falgy.2022.1007602. eCollection 2022.
3
[Biomarkers and functional tests in immediate hypersensitivity to SARS-CoV-2 mRNA vaccines].[新型冠状病毒mRNA疫苗速发型超敏反应中的生物标志物与功能检测]
Rev Fr Allergol (2009). 2022 Nov;62(7):624-627. doi: 10.1016/j.reval.2022.03.002. Epub 2022 Mar 11.
4
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions.2019冠状病毒病信使核糖核酸疫苗皮肤试验及过敏反应中的血清组胺水平
Ann Allergy Asthma Immunol. 2022 Mar;128(3):339. doi: 10.1016/j.anai.2021.12.014.
本文引用的文献
1
Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.通过疫苗和辅料过敏皮肤试验评估2019冠状病毒病疫苗超敏反应
Ann Allergy Asthma Immunol. 2022 Jan;128(1):97-98. doi: 10.1016/j.anai.2021.08.417. Epub 2021 Sep 3.
2
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.mRNA-1273 疫苗中 COVID-19 的过敏原成分：可能涉及聚乙二醇和 IgG 介导的补体激活。
Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun 17.
3
First Month of COVID-19 Vaccine Safety Monitoring - United States, December 14, 2020-January 13, 2021.2020 年 12 月 14 日至 2021 年 1 月 13 日，COVID-19 疫苗安全监测第一个月-美国。
MMWR Morb Mortal Wkly Rep. 2021 Feb 26;70(8):283-288. doi: 10.15585/mmwr.mm7008e3.
4
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
5
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine - United States, December 21, 2020-January 10, 2021.美国 2020 年 12 月 21 日-2021 年 1 月 10 日期间，在接种 Moderna COVID-19 疫苗第一针后出现过敏反应（包括过敏反应）。
MMWR Morb Mortal Wkly Rep. 2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1.
6
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals.抗聚乙二醇抗体：性质、形成、检测以及在聚乙二醇化纳米生物制药的不良反应中的作用。
Adv Drug Deliv Rev. 2020;154-155:163-175. doi: 10.1016/j.addr.2020.07.024. Epub 2020 Aug 1.
7
An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxis.IgG 诱导的中性粒细胞激活途径导致人类药物诱发的过敏反应。
Sci Transl Med. 2019 Jul 10;11(500). doi: 10.1126/scitranslmed.aat1479.
8
Vaccine-associated hypersensitivity.疫苗相关过敏反应。
J Allergy Clin Immunol. 2018 Feb;141(2):463-472. doi: 10.1016/j.jaci.2017.12.971.
Zotero 插件